Bilefoi
Natural health product licensed in Canada
- Licence holder
- Distribution Essentiel Moor Inc.
- NPN or DIN-HM
- 80033750
- Status
- Active licence
- Licence date
- 18 July 2012
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Marrubium vulgare Source : Parties aériennes | 50 mg | Not calculated |
| Cnicus benedictus Source : Parties aériennes | 50 mg | Not calculated |
| Silybum marianum Source : Graine(s) | 100 mg | Not calculated |
Non-medicinal ingredients
Stéarate de magnésium, Gélatine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | 2 days |
Uses authorised in Canada
Utilisé traditionnellement en herboristerie pour aider à soulager les troubles digestifs (dyspepsie), pour aider à stimuler l'écoulement de la bile et pour aider à stimuler la digestion.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contre-indications
Une hypersensibilité ou une allergie peut se manifester. Si tel est le cas, cesser l'utilisation.
Source
Official Health Canada record, licence 80033750
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.